Trials / Unknown
UnknownNCT03393234
Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer
Study of Safety and Feasibility of the Intersphincteric Resection With or Without Intraoperative Radiation in Low Rectal Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Second Hospital of Jilin University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to research on the safety and feasibility of ISR combined with low energy X ray intra-operative radiotherapy for the patients with local advanced rectal cancer.
Detailed description
Inter-sphincteric resection (ISR) has become an increasingly popular optional surgical tool for the treatment of very low rectal cancer. Nowadays, preoperative criteria for Lap ISR were the patients whose diagnosed with clinical stages T1-2 and N0\_1, which only a few patients with early stages can benefit from it. However, intra-operative radiotherapy with low energy X ray applied by Intrabeam is becoming an accepted radiotherapy technique for treatment of cancers. The purpose of this study was to research on the safety and feasibility of ISR combined with low energy X ray intra-operative radiotherapy for the patients with local advanced rectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Interoperative radiation by INTRABEAM using low energy X-ray | Intrabeam is a mobile Platform for Intraoperative Radiotherapy (IORT) produced by the ZEISS company in Germany.Interoperative radiation by INTRABEAM using low energy X-ray.The Intrabeam PRS appears to be a safe technique for delivering IORT in rectal cancer patients. |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2018-01-08
- Last updated
- 2018-01-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03393234. Inclusion in this directory is not an endorsement.